NCT00468221

Brief Summary

The purpose of this research study is to learn more about the effects of 0.12 ppm ozone exposure on humans. We know from other studies that exposure to levels of ozone that are seen on bad air pollution days, can cause an increased risk of illness and even death in some people with certain health problems like asthma and heart disease. We also know from studies we have done in our lab that even healthy people can have an inflammatory (an increase in the amount of bacteria fighting cells) response to high levels of ozone. We suspect that exposure to low levels of ozone makes the body more susceptible to things like allergens. For instance, in persons allergic to pollen, exposure to ozone in the environment may cause them to have more allergy symptoms when they are around pollen than they would have if they were not exposed to ozone first. In this study we are looking to find the lowest level of ozone to which healthy people can be exposed without seeing that increased immune response. We will use 0.12 ppm ozone; this is roughly the amount of ozone you would be exposed to on a "yellow" ozone day in the triangle area in the summer if you spent the entire day out of doors and exercising moderately.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2009

Typical duration for phase_1 healthy

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 2, 2007

Completed
2.1 years until next milestone

Study Start

First participant enrolled

June 1, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

May 29, 2015

Status Verified

May 1, 2015

Enrollment Period

5 months

First QC Date

April 30, 2007

Last Update Submit

May 27, 2015

Conditions

Keywords

OzoneHealthy Adults

Outcome Measures

Primary Outcomes (1)

  • Inflammatory markers in sputum

    post exposure

Interventions

Low dose ozone exposure in chamber

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy Adult
  • Nonsmoker
  • Able to perform light exercise

You may not qualify if:

  • Asthma
  • active allergies
  • chronic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Bradford Harris, MD

    University of North Carolina

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 30, 2007

First Posted

May 2, 2007

Study Start

June 1, 2009

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

May 29, 2015

Record last verified: 2015-05